Rather unusually for a biotech IPO, today Maxygen went public very successfully. They are using directed molecular evolution. The founder has also co-founded several other successful companies including Affymetrix. Full story:
http://www.cnbc.com/commentary/commentary_full_story_stocks.asp?StoryID=9836
Max